Scholarly Index
Cheng Luo
Central South University; 18,664 total citations; 546 total publications; best world rank #152
Central South University
18,664Total citations
546Total publications
64H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Epigenetics and DNA Methylation | Lifetime | 989 | CN 99 | 97.87 |
| Cancer-related gene regulation | Lifetime | 547 | CN 63 | 97.42 |
| Protein Degradation and Inhibitors | Lifetime | 490 | CN 21 | 96.43 |
| Histone Deacetylase Inhibitors Research | Lifetime | 545 | CN 50 | 95.28 |
| Epigenetics and DNA Methylation | 2021-2025 | 407 | CN 154 | 94.09 |
| Ubiquitin and proteasome pathways | 2021-2025 | 152 | CN 74 | 93.78 |
| Ferroptosis and cancer prognosis | 2021-2025 | 861 | CN 730 | 90.56 |
| Cancer-related gene regulation | 2021-2025 | 336 | CN 227 | 88.03 |
| Protein Degradation and Inhibitors | 2021-2025 | 536 | CN 100 | 90.12 |
| Natural product bioactivities and synthesis | 2021-2025 | 879 | CN 417 | 81.20 |
| Histone Deacetylase Inhibitors Research | 2021-2025 | 696 | CN 203 | 78.62 |
| Cancer-related Molecular Pathways | 2021-2025 | 847 | CN 181 | 73.51 |
| Phytochemical compounds biological activities | 2021-2025 | 384 | CN 152 | 67.15 |
| NF-κB Signaling Pathways | 2021-2025 | 347 | CN 138 | 57.24 |
| Glutathione Transferases and Polymorphisms | 2021-2025 | 256 | CN 59 | 56.16 |